Introduction {#Sec1}
============

Worldwide, early HIV testing is a public health priority especially among key populations such as female sex workers (FSWs) \[[@CR1]--[@CR3]\]: out of the estimated 33 million people living with HIV in the world, 19 million do not know their status \[[@CR1]\]. Early HIV diagnosis has gained significant attention within key global health institutions, including the Joint United Nations Program on HIV/AIDS (UNAIDS) and the recently established 90-90-90 targets \[[@CR4]\]. It is proposed that by 2020, 90% of all people living with HIV should know their HIV status, 90% of all people with diagnosed HIV should receive sustained antiretroviral treatment, and 90% of all people receiving antiretroviral treatment should reach viral suppression \[[@CR4]\]. Historically, HIV prevention efforts focused on key populations, including sex workers, as an effective approach to reduce HIV transmission, particularly in the early phase of the epidemic \[[@CR5]\].

Several systematic reviews have examined HIV prevalence \[[@CR6]--[@CR8]\] and effectiveness of different HIV prevention interventions for SWs \[[@CR9]--[@CR12]\]. Shahmanesh et al. presented evidence for the efficacy of multi-component interventions, and⁄or structural interventions \[[@CR9]\]. A Cochrane review of behavioral interventions concluded that, compared with standard care or no intervention, behavioral interventions are effective in reducing HIV and the incidence of STIs amongst FSWs \[[@CR10]\]. A systematic review of community empowerment interventions in low- and middle-income countries demonstrated significant protective combined effect for HIV infection (prevalence), STIs such as gonorrhea and chlamydia, and increase of consistent condom use with all clients \[[@CR12]\]. A systematic review of community empowerment interventions in generalized and concentrated epidemics has shown their positive impact on HIV prevalence, estimated number of averted infections among SWs and adult population, and expanded coverage of ART \[[@CR11]\]. These previous studies did not systematically assess HIV testing approaches, but rather examined the combined effect of a variety of prevention activities. Thus, they failed to address unique determinants of different HIV testing approaches.

HIV testing activities among sex workers were assessed in only two papers including a meta-analysis of community-based approaches \[[@CR13]\], and a study of barriers to HIV testing in Europe \[[@CR14]\]. According to these studies, community-based HIV testing leads to higher HIV testing rates than facility-based testing, and the most common barriers to HIV testing are low-risk perception, fear and worries, poor accessibility to healthcare services, health providers' reluctance to offer the test, and scarcity of financial and human resources. Still, neither of those studies focused on FSWs nor systematically reviewed unique facilitators and barriers to HIV testing faced by this group. The present review compiles existing evidence on HIV testing among FSWs in order to better meet the needs of this group while implementing the first target of the 90-90-90 strategy. Our specific objectives are: (1) to summarize data on key barriers and facilitators to HIV testing among FSWs, and (2) to systematically review frequencies of testing, willingness to test, and return rates to collect HIV test results in this population.

Methods {#Sec2}
=======

We applied a free text strategy and MeSH terms to systematically scan the electronic databases MEDLINE/PubMed using the platform OVID, and EMBASE and SCOPUS. We employed a combination of terms that covered the concepts 'HIV', 'Sex work' and 'Test'. We conducted several scoping searches to identify the most efficient search strategy, which we provide in "[Annex 1: Search strategy](#Sec23){ref-type="sec"}". Guidelines, reports and policy documents were searched using Google Scholar and employed to inform the discussion of findings. We exported all identified references (5036) into the bibliographic management software ENDNOTE X7.

The first author (AT) screened titles and abstracts against the following inclusion criteria: (1) published in a peer-reviewed journal between January 2000 and November 2017; (2) written in English; and (3) presenting data on HIV testing among FSWs. We excluded duplicates and studies for which no abstract or full text was available (N = 17). After reviewing the full text of 95 pre-selected articles against the above mentioned inclusion criteria, 36 papers were retained for a more detailed review. The first author extracted data systematically using a standardized form that included information on the period of study, location, study population, design, research questions, key findings, and conclusions ("[Annex 2: Data extraction form](#Sec24){ref-type="sec"}"). Next the quality of qualitative papers was assessed using the guide for critically appraising qualitative research by Spencer et al. \[[@CR15]\]. The modified *Downs and Black* checklist was applied to quantitative and mixed-methods papers \[[@CR16]\]. We used a midpoint score of 9 for qualitative papers and 12.5 for quantitative ones as a cut off between low- and high-quality studies. Overall, two quantitative papers with score of 10 \[[@CR18]\] and 9 \[[@CR17]\] points failed to meet the criteria; three papers received 12 points \[[@CR19], [@CR20]\]. The vast majority of quantitative papers lacked information needed for assessment. We were unable to appraise four abstracts: three, for the limited data presented, and one, being a mathematical modeling paper \[[@CR21]\] that did not fit well with the quality appraisal tools employed. We decided to include all papers into the review in order to provide a comprehensive picture; at the same time, we considered it important to stress the results of the quality assessment ("[Annex 3: Quality assessment](#Sec25){ref-type="sec"}"). The results of the search and screening process are described in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1PRISMA flow chart of citations

Guided by the socio-ecological model (SEM) developed by Blanchard et al. \[[@CR22]\] we classified data into three levels: macro-, meso-, and micro-level factors (Table [1](#Tab1){ref-type="table"}). The macro level consisted of economic and policy factors. The meso level included social networks, organizations, cultural norms, and values. The micro level included individual socio-demographic characteristics, knowledge, risk awareness, and behavioral factors. We also extracted data on previous experiences of HIV testing and ways to encourage uptake. The PRISMA check list is provided as "[Annex 4: PRISMA 2009 Checklist](#Sec26){ref-type="sec"}".

Results {#Sec3}
=======

Out of the 36 studies retained for review, most were quantitative (N = 20) and conducted in Asia (N = 18). Nine papers reported work conducted in Africa, three in Europe, three in Russia, and one in Macedonia. Three studies were conducted in Latin America, two in Canada and one in Australia. Eighteen studies were cross-sectional, and twenty-five focused exclusively on FSWs.

Previous Experience of HIV Testing {#Sec4}
----------------------------------

We summarized evidence on previous experience of HIV testing and approaches to facilitate testing (Table [1](#Tab1){ref-type="table"}). Fifteen studies \[[@CR17], [@CR18], [@CR23]--[@CR35]\] focused on ever in life testing. The highest rate was reported in a study in Russia where all recruited FSWs (100%, N = 29) were tested \[[@CR24]\] followed by Kenya (88.6%, N = 818) \[[@CR27]\]. The lowest rate was reported in a study conducted in India (7.9%, N = 6648) \[[@CR18]\]. Ten studies examined recent testing \[[@CR25], [@CR27]--[@CR29], [@CR35]--[@CR40]\], which varied extensively from 76.1% in Canada (N = 435) \[[@CR25]\] to 22% in China (N = 970) \[[@CR38]\]. Six studies addressed willingness to test \[[@CR18]--[@CR20], [@CR28], [@CR41], [@CR42]\], and this ranged from 88% (N = 17) in China \[[@CR41]\] to 73.2% in India (N = 6648) \[[@CR18]\]. Three studies reported that willingness facilitated actual HIV testing \[[@CR20], [@CR28], [@CR41]\]. Only four studies assessed frequencies of collecting test results \[[@CR23], [@CR26], [@CR33], [@CR43]\], and these ranged widely from 92.3% in Guinea \[[@CR26]\] to 14.8% in Thailand \[[@CR43]\].Table 1Overview of selected studiesStudy referenceLocationStudy population (N, population group)Study designHIV testing uptakeMicro-level factorsBarriersFacilitators1. Aho et al. \[[@CR26]\]GuineaN = 421\
FSWsMixed (QN,CS & QL)Ever tested:26.6%\
Acceptance:100%\
Collected result:92.3%n/aHigher perceived risk2. Ameyan et al. \[[@CR47]\]EthiopiaN = 20 FSWs\
N = 3 community counsellors\
N = 3 HCWs\
N = 3 program managers\
N = 2 hotel ownersQLn/aLower perceived riskYoung age\
HIV knowledge\
Pregnancy, children3. Batona et al. \[[@CR28]\]BeninN = 450\
FSWsQN,CSEver tested:87%\
Past year::65.3%\
Past 3 months:40%\
3--6 months:21%\
Acceptance:98.9%\
Willing:69.4%n/aPrevious testing\
Having kids4. Beattie et al. \[[@CR48]\]IndiaN = 302 FSWs = 125\
MSM = 56\
TSG = 6\
Female peer educators = 87\
Male peer educators = 28QLn/aNo ill health symptoms\
Poor VCT knowledgeImproved quality &duration of life (ART)\
Having kids5. Bengtson et al. \[[@CR27]\]KenyaN = 818\
FSWsQN, CSEver tested:88.6% Never tested:11%\
Every 3 months:45%\
Every 6 months:15%\
Every 1--3 months:12%\
Once:16%31 years and older\
Less than 7 years of SW\
Alcohol useHaving kids6. Burke et al. \[[@CR54]\]UgandaN = 88 \
N = 11 FSWs\
N = 10 Fish men/boat owners\
N = 12 HCWs\
N = 55 community membersQLn/an/an/a7. Chanda et al. \[[@CR49]\]ZambiaN = 40\
FSWsQLn/an/aPregnancy\
Protecting one's child\
Seeking birth control\
Family planning\
Higher HIV knowledge8. Chiao et al. \[[@CR45]\]PhilippinesN = 980\
FSWs (baseline)\
N = 903\
FSWs\
(post test)QN, randomized quasi-experimentaln/an/aOlder age\
Better educated\
Longer employed in SW\
Regular SP\
Higher income\
Higher HIV knowledge\
Higher perceived risk9. Dandona et al. \[[@CR18]\]IndiaN = 6648\
FSWsQN,CSEver tested:7.9%\
Unwilling:73%16--17 years old\
Low incomeEngaged in SW \> 5 years\
Higher income10. Deering et al. \[[@CR37]\]CanadaN = 291\
SWsQN,CSPast year: 69.4%n/an/a11. Deering et al. \[[@CR25]\]CanadaN = 435\
SWsQN,CSEver tested:87.4%\
Past year:76.1%Migrant/new migrant\
Language barriersOlder age of SW initiation\
Aboriginal ancestry\
Inconsistent condom use with clients\
Injecting drugs\
Contact with nursing program12. Dugas et al. \[[@CR29]\]BeninN = 66\
FSWs\
N = 24\
HCWsQLEvery 6 months:46%\
Never tesed:26%No symptoms\
Migration\
Language barriersn/a13. Grayman et al. \[[@CR30]\]VietnamN = 610 FSWsQN,CSEver tested:30.9%Never married\
5 or fewer clients per weekn/a14. Hong et al. \[[@CR31]\]China*N* = 1022 FSWsQN,CSEver tested:48%Lower perceived risk\
Inconsistent condom use with client/stable SP\
Poor VCT knowledgeHigher HIV knowledge\
Older age\
Low education15. King et al. \[[@CR46]\]RussiaN = 29\
FSWsQLEver tested:100%Drug use\
PovertyHaving money16. King et al. \[[@CR46]\]RussiaN = 139 FSWsQN,CSn/aOlder age\
Longer duration of drug usen/a17. King et al. \[[@CR34]\]RussiaN = 139 FSWs\
N = 29 FSWsMixed (QN,CS& QL)Ever tested: 97--100%Drug use\
Drug use for ≥ 4 years\
Poor knowledge where to testHigher HIV knowledge\
Perceived risk\
High HIV incidence\
Knowing someone who is HIV+\
Wanting to protect others (children, parents)18. Johnston et al. \[[@CR40]\]Dominican RepublicN = 2781\
FSWsQN, CSPast year: 16.6--30.8%n/aHigher HIV knowledge\
Regular HC checks-19. Ngo et al. \[[@CR50]\]VietnamN = 30 FSWs (in-depth interview)\
N = 94\
FSWs (FGDs)QLn/aPoor VCT knowledge\
Perceived riskFear of HIV\
Visual STI symptoms\
Drug use of intimate SP20. Nhurod et al. \[[@CR43]\]ThailandN = 1006 FSWsQN,CSAcceptance:91.2%\
collected result:at clinic-100%\
at mobile point-14.8%n/an/a21. Park et al. \[[@CR38]\]ChinaN = 348\
FSWsQN,CSPast year:22%n/aHigher HIV knowledge\
Participation in HIV prevention program\
Income\
Education\
Regular STI checks22. Parriault et al. \[[@CR17]\]Boarder between Brazil and French GuianaN = 213\
FSWsQN, CSNever tested: 31%Older age\
HIV knowledge\
Poor knowledge where to test\
Lower perceived riskn/a23. Sayarifard et al. \[[@CR36]\]IranN = 128 FSWsQN,CSPast year:25%Poor knowledgen/a24. Scorgie et al. \[[@CR52]\]four countries of east and southern Africa (Kenya, Zimbabwe, Uganda and South Africa)N = 106 FSWs N = 26 MSWs *N* = 4 TSGQLn/aPoor VCT knowledgen/a25. Shokoohi et al. \[[@CR35]\]IranN = 1005 FSWsQN, CSPast year 27.5%n/aOlder age at first SW\
HIV knowledge\
Knowledge where to test\
Injecting drugs ever in life\
Receiving free condoms during 12 months\
Higher perceived risk26. Shokoohi et al. \[[@CR39]\]IranN = 1337\
FSWsQN, CSEver tested:80.6%\
Past year 70.4%n/aHigher educational level\
Higher HIV knowledge\
Knowledge of where to test\
More than 5 paying SP\
More than one none-paying SP\
Consistent condom use\
Receiving HR services\
Health service utilization\
Higher perceived risk27. Simonovikj et al. \[[@CR53]\]MacedoniaN = 106 SWsCase reportn/an/an/a28. Todd et al. \[[@CR32]\]UzbekistanN = 448 FSWsQN,CSEver tested:83.9%Younger age\
Initiated SW before age 18\
Shared drugs with clients\
Consistent condom use with clients\
Shorter period of SW\
Fewer SP\
Poor VCT knowledgen/a29. Tran et al. \[[@CR33]\]VietnamN = 1998 FSWsQN,CSEver tested: 34.4% ESWs 24.4%-SSWs\
Collected result:86.9%Ever injected drugs\
Having IDUs as clients\
Inconsistent condom use with non-commercial SP lover and husband)Duration of SW\
Inconsistent condom use with clients\
Higher HIV knowledge (information via communication campaign)\
Higher perceived risk30. Wang et al. \[[@CR41]\]ChinaN = 17 FSWs\
N = 12 pimpsQLWilling:88%Poor HIV knowledge (receiving information through TV on decrease of HIV P)\
HIV negative-peers/friends\
Lower perceived risk\
Consistent condom useHigher risk awareness (receiving information through TV on increase of HIV P)\
Someone close diagnosed HIV+\
Concerned about friends and family\
Concerned about one's health31. Wang et al. \[[@CR19]\]ChinaN = 970\
FSWsQN,CSWilling:69%\
Unwilling:7.2%n/aMarried\
Engaged in SW for longer\
Higher VCT knowledge\
Higher perceived risk\
Condom use\
Leave SW\
Previous HIV testing32. Wang et al. \[[@CR20]\]ChinaN = 970\
FSWsQN, Prospective cohortWilling:69%\
Acceptance:11%Lower perceived riskEngaged in SW \> 12 months\
Condom use\
Willing to test\
Changing job33. Wanyenze et al. \[[@CR51]\]Uganda*N* = *190* FSWsQLn/aPoor HIV knowledge\
Misconceptions\
Limited awareness of servicesn/a34. Wilson et al. \[[@CR21]\]AustraliaN = n/a\
SWsMathematical modeln/an/an/a35. Xun et al. \[[@CR42]\]ChinaN = 371 MSM\
N = 405 FSWs\
*N* = 361 VCT clientsQN,CSWilling:72.1%\
-54.3% at homen/aWilling to pay 4.8 USD for oral test\
Higher risk awareness36. Xu et al. \[[@CR23]\]ChinaN = 164\
FSWsQN\
longitudinalEver tested:32.1%-HIV+ , 16.1%-HIV−\
Collected result:47.8%n/aMore than 9 years of schooling\
Less than 5 clients per week\
Having a regular SP\
Drug use\
Pelvic pain during last 12 months\
Higher perceived riskStudy referenceMeso-level factorsMacro-level factorsStrategies to encourage HIV testingBarriersFacilitatorsBarriersFacilitators1. Aho et al. \[[@CR26]\]HIV stigma\
SW stigma\
Managers' negative attitudePeer supportn/aFree treatmentn/a2. Ameyan et al. \[[@CR47]\]HIV stigma and discrimination\
Time restriction\
Higher travel costs\
Negative attitude of HCWs\
Negative experience of peers/brothel ownersPrivate hospitals\
Financial incentivesNeed to show ID\
Poor confidentialityFree treatment and other HC servicesInvolvement of brothel owners\
Involvement of media\
Media3. Batona et al. \[[@CR28]\]n/an/an/an/an/a4. Beattie et al. \[[@CR48]\]Fear of HIV+ result, HIV +status/SW disclosure\
Fear to leave the brothel (violence)\
Discrimination of FSWs/HIV+\
Higher travel costs\
Time costsPeer supportLack of confidentiality\
Bribes\
ID and retention\
Need to have retention "buddy"n/aPeer educators5. Bengtson et al. \[[@CR27]\]n/an/an/an/an/a6. Burke et al. \[[@CR54]\]n/an/an/an/aSelf-testing7. Chanda et al. \[[@CR49]\]Fear of stigma and discrimination\
HIV stigma\
SW stigma\
Intimate partner violence\
Potential financial\
Time restrictionsCommunity/close social networkFear of poor confidentialityn/aCommunity empowerment\
Norm-changing interventions8. Chiao et al. \[[@CR45]\]n/aSupport from peers and managersn/an/aEducation of peers and managers9. Dandona et al. \[[@CR18]\]Non-participation in self support groupNon street-based\
Participation in support groupn/an/an/a10. Deering et al. \[[@CR37]\]n/aHigh density of testing sites\
Lower travel costsn/an/an/a11. Deering et al. \[[@CR25]\]Indoor SWn/aCriminalization of SWn/an/a12. Dugas et al. \[[@CR29]\]Fear of HIV+ test result\
Fear of SW disclosure\
Low quality of HCPeer-educators\
Pimps' supportn/an/aPeer educators\
Home/work testing\
Community mobilization13. Grayman et al. \[[@CR30]\]n/an/an/aTime ever spent in rehabilitation centre for drug addictsn/a14. Hong et al. \[[@CR31]\]Fear of HIV+ status disclosure\
Fear of SW disclosure\
Higher time costsWorking at high income venuesn/an/an/a15. King et al. \[[@CR46]\]Perceived low quality of public HC services\
Social marginalizationFamily support\
Having relatives employed as medical professionals\
Personal "connections" with HC system\
Referrals of NGOs\
More accessible private hospitalBribes\
Residence permit\
Fear of registration as drug user, STI patient or HIV+ in official medical records\
Need to give up possibility of anonymity\
Underfunding of HC\
Illegal SWOutreach program/referralsOutreach with the referrals16. King et al. \[[@CR46]\]HIV stigma\
Refusal of medical care (IDUs, FSWs)SW stigmaPoor confidentialityn/an/a17. King et al. \[[@CR34]\]Higher time and travel costs\
Fear of HIV+ test result\
SP reaction if tested HIV+\
Stigma and discriminationSocial support\
Perceived better conditions in private clinicsPoor confidentiality\
High costs\
residence permit\
Fear of registration as drug user, STI patient or HIV+ in official medical recordsFree treatment\
Outreach vanOutreach testing18. Johnston et al. \[[@CR40]\]n/aSocial supportn/an/an/a19. Ngo et al. \[[@CR50]\]Street based SW\
Higher time costs (waiting lists)\
Lack of money&time\
Fear of HIV+ result\
Fear to be recognized as SW\
Discrimination, unfriendly perceived low quality of public hospitals\
Fear of imprisonment if diagnosed HIV+Venue-based SW\
Managers requirement to test\
Perceived high quality (no waiting, less of private) private HC facilitiesPoor confidentiality, HC costs at private hospitalsLess perceived discrimination at private clinics\
Free treatment\
Abortion, giving birth or rehabilitation centre for drug addictsInvolvement of managers\
Peer-referrals20. Nhurod et al. \[[@CR43]\]Higher time costs\
Money needed to travel to collect test result checkRequired negative result to be employed as SWn/an/aMobile VCT\
Rapid testing21. Park et al. \[[@CR38]\]n/aSW venuen/an/aCooperation of NGO and FSWs' network22. Parriault et al. \[[@CR17]\]n/an/an/an/an/a23. Sayarifard et al. \[[@CR36]\]Fear of HIV+ result\
Fear of result disclosuren/aHigher costsn/aTraining program for FSWs24. Scorgie et al. \[[@CR52]\]Self-stigma\
Fear of HIV+ result\
Fear of isolation and discrimination\
Higher transportation costsNGO established clinic\
Perceived higher quality of private HC facilitiesForced testing without consent\
Denial of testing\
Illegal SWn/aTraining of health providers\
Supporter or advocate in HC facilities\
Collective action of SWs25. Shokoohi et al. \[[@CR35]\]n/an/an/aRapid testing26. Shokoohi et al. \[[@CR39]\]n/an/an/an/aReferral's\
Community-based outreach testing\
Self-testing27. Simonovikj et al. \[[@CR53]\]n/an/aCases of forced testing during police arrestn/an/a28. Todd et al. \[[@CR32]\]n/an/aCompulsory testing during police detainment\
Illegal SW\
Fees for testing and treatmentn/aChange in criminal law\
Guarantee anonymous testing\
Establishment of "friendly cabinets"29. Tran et al. \[[@CR33]\]n/an/a54% were tested voluntarily, other were forcedn/an/a30. Wang et al. \[[@CR41]\]Fear of HIV+ result\
Meeting friends at VCT sites\
Fear of HIV+ diagnosis\
Lack of confidentiality\
Fear of HIV + disclosure\
Fear of sex work disclosure\
Stigma\
Higher time costsSupport from peers and managersFear of being quarantined\
Higher medical cost\
Mistrust in governmental free servicesn/aEducation information\
Dissemination31. Wang et al. \[[@CR19]\]Stigmatization and discriminationSupport from peers, family, and managersn/aFree treatmentPeer education -VCT promotion32. Wang et al. \[[@CR20]\]Stigmatization and discrimination\
SW disclosureSupport from peersn/aFree treatmentPeer education33. Wanyenze et al. \[[@CR51]\]Fear of stigma and discrimination\
Unwelcoming attitude of HC workers and discrimination\
Stigmatization by fellow sex workers, families and the community\
Unfavourable opening hours of health facility\
The pace at which HIV services are deliveredSocial networksCosts ("tips" to healthcare providers)\
Fear of breach of confidentiality\
Illegal SWFaster service delivery at private facilitiesUse of media\
Establishing specific facilities or clinics for SWs\
Provision of health information on phones\
Motivation and sensitization of HC providers to work with FSWs34. Wilson et al. \[[@CR21]\]n/an/aMandatory HIV testing not cost effectiven/an/a35. Xun et al. \[[@CR42]\]n/an/an/an/aOral fluid test\
Home testing36. Xu et al. \[[@CR23]\]n/an/an/an/an/a*ART* antiretroviral therapy, *CS* cross sectional, *EES* entertainment-based sex workers, *FGDs* focus group discussions, *FSWs* female sex workers, *HC* health care, *HCWs* healthcare workers, *HIV* human immunodeficiency virus, *HIV P* HIV prevalence, *HR* harm reduction, *IDUs* injection drug users, *ID* identity card, *MSM* men who have sex with men, *MSWs* male sex workers, *NGO* non-governmental organizations, *SP* sexual partner, *STI* sexually transmitted infections, *SSWs* street-based sex workers, *SW* sex work, *TSG* transgender, *QN* quantitative, *QL* qualitative, *n/a* non applicable, *VCT* voluntary counselling and testing

We identified a high variability of outcome measures employed in the studies reviewed. For example, the frequency of HIV testing was measured using different time frames and included "last month" and "recent testing" with a time period corresponding to "recent" that varied from 1 year to 1 month.

Conceptual Framework: Barriers and Facilitators of HIV Testing Amongst FSWs {#Sec5}
---------------------------------------------------------------------------

In this study we employed an adapted version of the socio-ecological framework developed by Blanchard et al. \[[@CR22]\] to organize and analyze our findings systematically. As shown in Fig. [2](#Fig2){ref-type="fig"}, we conceptualized HIV test uptake as the result of a number of interrelated factors that operate simultaneously at the micro, meso and macro levels. Most articles focused on the micro (N = 30) and meso (N = 24) levels, and about half of all papers addressed the macro (N = 19) level. Ten studies analyzed concurrently two levels of the *social ecology,* while nine addressed simultaneously the micro, meso, and macro levels.Fig. 2Conceptual framework: barriers and facilitators of HIV testing amongst FSWs.Reproduced with Permission from Blanchard et al. \[[@CR22]\]

Micro-level Factors {#Sec6}
-------------------

### Socio Demographic Characteristics {#Sec7}

Sixteen articles focused on socio-demographic characteristics. We found no consistent associations \[[@CR18], [@CR27], [@CR31], [@CR32], [@CR44]--[@CR46]\] of education and age \[[@CR23], [@CR31], [@CR45]\] with HIV testing uptake. Highly educated women in the Philippines and Iran were more likely to test \[[@CR39], [@CR45]\], but studies in China reported higher HIV testing uptake amongst women with both high \[[@CR23]\] and low education level \[[@CR31]\]. In two studies conducted in China and one in the Philippines, older age facilitated HIV testing \[[@CR31], [@CR44], [@CR45]\], but in Russia, Ethiopia and Kenya older-aged FSWs \[[@CR46], [@CR47]\] and those aged + 30 \[[@CR27]\] were less likely to test compared to younger FSWs. In Uzbekistan and India, younger age decreased testing \[[@CR18], [@CR32]\]. Higher income was associated with testing in India and the Philippines \[[@CR18], [@CR45]\] and in Russia poverty impeded access to healthcare, including HIV testing \[[@CR24]\].

Ten studies reported that having children and/or being pregnant and/or being in a permanent relationship facilitated HIV testing \[[@CR19], [@CR23], [@CR27], [@CR28], [@CR30], [@CR34], [@CR45], [@CR47]--[@CR49]\]. Married women in China \[[@CR19]\] and those with a regular sexual partner in the Philippines \[[@CR45]\] and in China \[[@CR23]\] were more likely to test. According to a study conducted in Vietnam, unmarried women were less likely to test \[[@CR30]\]. In Kenya, Zambia, Benin, Ethiopia, Russia and India, having children or being pregnant facilitated HIV testing \[[@CR27], [@CR28], [@CR34], [@CR47]--[@CR49]\]. In Iran, incarceration was associated with recent testing \[[@CR39]\].

In Canada and Benin, migrant FSWs \[[@CR25], [@CR29]\] had limited access to healthcare because of language barriers, which led to low HIV testing rates.

### Risk Behaviors {#Sec8}

Seven studies reported nearly inconsistent patterns on how regular condom use influenced HIV testing. Using condoms during every instance of each sexual intercourse both facilitated and impeded testing depending on the type of sexual partner \[[@CR19], [@CR20], [@CR25], [@CR31], [@CR33], [@CR39], [@CR41]\]. Three articles reported that inconsistent condom use with a client -facilitated testing \[[@CR25], [@CR31], [@CR33]\], but using condoms inconsistently with a husband or lover was negatively associated with testing \[[@CR33]\]. In China, a quantitative study identified that condom use was associated with HIV testing \[[@CR20]\], although in a previous qualitative study the same author found that FSWs who used condoms consistently felt to be sufficiently protected from HIV and not in need of testing \[[@CR41]\]. In Iran, consistent condom use during each sexual intercourse was associated with recent testing \[[@CR39]\].

Initiation of sex work at an older age \[[@CR18], [@CR20], [@CR33], [@CR35], [@CR45]\] and engaging in sex work for a longer period of time \[[@CR18], [@CR20], [@CR33], [@CR45]\] facilitated HIV testing. In Uzbekistan, FSWs who started sex work before the age of 18 were less likely to test \[[@CR32]\], and in Canada older age of sex work initiation was positively associated with recent testing \[[@CR25]\]. FSWs who engaged in sex work for a longer time had a higher uptake of testing \[[@CR18], [@CR20], [@CR33], [@CR45]\] and willingness to test \[[@CR19]\]. FSWs employed for shorter periods \[[@CR27], [@CR32]\] were less likely to test.

Having a lower number of clients/sexual partners was associated with HIV testing in China \[[@CR23]\], but was reported to decrease testing in Vietnam \[[@CR30]\], Iran \[[@CR39]\] and Uzbekistan \[[@CR32]\].

Most studies identified drug use and alcohol consumption to impede HIV testing \[[@CR24], [@CR25], [@CR27], [@CR32]--[@CR34], [@CR46]\]. Still, in Iran and Canada drug use among FSWs did not hinder testing \[[@CR25], [@CR35]\].

### Risk Awareness {#Sec9}

We reviewed thirteen articles that focused on individual perceptions towards HIV risks \[[@CR19], [@CR20], [@CR23], [@CR26], [@CR31], [@CR33]--[@CR35], [@CR39], [@CR41], [@CR45], [@CR47], [@CR50]\]. Low perceived risk was associated with lower likelihood to test \[[@CR31], [@CR45], [@CR47]\], and FSWs would be less likely to test if they believed that HIV prevalence to be decreasing and no one in their social network was infected \[[@CR41]\]. Conversely, high perceived risk was associated with HIV testing \[[@CR19], [@CR23], [@CR26], [@CR33]--[@CR35], [@CR39], [@CR41], [@CR45], [@CR50]\].

### HIV-Related Knowledge {#Sec10}

Seventeen articles examined HIV knowledge, including knowledge of available HIV testing sites in the area \[[@CR19], [@CR29], [@CR31], [@CR33]--[@CR36], [@CR38]--[@CR41], [@CR45], [@CR47]--[@CR51]\]. FSWs who had heard prevention messages in HIV communication campaigns were more likely to test \[[@CR33], [@CR47], [@CR51]\]. Similarly, FSWs were reluctant to test if they had poor HIV-related knowledge \[[@CR29], [@CR36], [@CR41], [@CR48], [@CR49], [@CR51]\] and were not well informed about local testing sites \[[@CR31], [@CR41], [@CR48], [@CR50]--[@CR52]\].

Meso-level Factors {#Sec11}
------------------

### Sex Work Venue {#Sec12}

Of the six articles that addressed sex work venues \[[@CR18], [@CR25], [@CR31], [@CR41], [@CR45], [@CR50]\], most reported that working indoors and at high-income venues generating higher income impelled HIV testing. Working in a high-income venue and out of the street predicted testing in China, Vietnam and India \[[@CR18], [@CR31], [@CR50]\]. However, in Canada, FSWs working indoors were less likely to have recently tested for HIV than those working outdoors \[[@CR25]\].

### Social Support {#Sec13}

About half of the articles reviewed assessed how FSWs' social interactions influenced their decision to test for HIV \[[@CR18]--[@CR20], [@CR24], [@CR26], [@CR29], [@CR34], [@CR38], [@CR40], [@CR41], [@CR43], [@CR45], [@CR47]--[@CR51]\]. Positive attitudes and support from peers, family and partners facilitated HIV testing \[[@CR19], [@CR20], [@CR24], [@CR26], [@CR29], [@CR34], [@CR40], [@CR41], [@CR45], [@CR48]--[@CR51]\]. In China, women were more likely to test if accompanied by peers \[[@CR19], [@CR20]\]. In Russia, family support was an important condition for accessing healthcare, including HIV testing, as women could rely on their family financially and emotionally \[[@CR24]\]. Participation in self-support groups in India \[[@CR18]\] and Uganda \[[@CR51]\] and receiving condoms from HIV prevention programs in China \[[@CR38]\] facilitated testing. Positive views of FSWs' employers towards HIV testing \[[@CR41], [@CR45]\] or requiring the test \[[@CR43], [@CR50]\] increased the uptake. However, in China and Ethiopia, employers expressed concerns towards HIV testing and how it could impact the sex work business \[[@CR41], [@CR47]\]. In Guinea, HIV testing was forbidden by some managers \[[@CR26]\]. In Zambia and Russia, fear of negative reaction of their sexual partner if diagnosed HIV-positive, prevented women from engaging in HIV testing \[[@CR34], [@CR49]\].

### Stigma and Discrimination {#Sec14}

A total of fourteen articles focused on stigma and discrimination of HIV+ people and/or sex workers \[[@CR20], [@CR24], [@CR26], [@CR29], [@CR31], [@CR34], [@CR36], [@CR41], [@CR46]--[@CR52]\]. Fears of being identified as HIV+ \[[@CR24], [@CR26], [@CR31], [@CR34], [@CR36], [@CR41], [@CR47]--[@CR51]\] or as a sex worker \[[@CR20], [@CR26], [@CR31], [@CR34], [@CR41], [@CR46]--[@CR52]\] were reported as barriers to testing in a number of studies. FSWs could refuse HIV testing \[[@CR29], [@CR36], [@CR41], [@CR48], [@CR50], [@CR52]\] or fail to collect test results \[[@CR48]\] if afraid of receiving an HIV+ diagnosis.

In Benin, healthcare workers reported that women did not like to be recognized as FSWs, and that this could prevent them from seeking healthcare \[[@CR29]\]. In several African countries, health providers discriminated against sex workers and their family members \[[@CR52]\]. In Russia, FSWs were concerned that they would be treated badly or denied healthcare if identified as sex workers or drug users \[[@CR46]\]. In China, FSWs worried about meeting an acquaintance at the testing site and being recognized as HIV+ \[[@CR41]\], while in Vietnam, they feared imprisonment if diagnosed with HIV \[[@CR50]\]. Self-stigma resulting from widespread negative views of HIV+ people and sex work decreased testing across several African countries \[[@CR52]\]. Thirteen articles reported that anticipated stigma and discrimination at health facilities hampered service utilization \[[@CR19], [@CR20], [@CR24], [@CR26], [@CR29], [@CR37], [@CR41], [@CR46], [@CR48]--[@CR52]\]. In Russia, Vietnam, Uganda and several African countries, private hospitals were defined by FSWs as more friendly and of higher quality than public health facilities, and were reported to be preferable places to get healthcare services, including HIV testing \[[@CR24], [@CR50]--[@CR52]\].

### Time and Transport Costs {#Sec15}

Eleven articles reported that time and transport costs hampered access to healthcare \[[@CR24], [@CR31], [@CR34], [@CR36], [@CR37], [@CR41], [@CR43], [@CR47], [@CR49]--[@CR52]\]. Time restraints impeded testing in China \[[@CR31], [@CR41]\], India \[[@CR48]\], Thailand \[[@CR43]\], Vietnam \[[@CR50]\], Uganda \[[@CR51]\], Zambia \[[@CR49]\], Ethiopia \[[@CR47]\] and several other African countries (Kenya, Zimbabwe, Uganda and South Africa) \[[@CR52]\]. In Uganda, Zambia and Russia, FSWs expressed dissatisfaction with opening hours of health facilities as they did not correspond with women's schedules and caused financial and time loss \[[@CR34], [@CR49], [@CR51]\]. In Canada, higher density of testing sites and little time needed to get there were associated with having tested recently \[[@CR37]\]. In Thailand, travel costs were reported to prevent users from collecting their HIV test results \[[@CR43]\].

Macro Level Factors {#Sec16}
-------------------

### HIV Testing Policies {#Sec17}

Eleven articles focused on HIV testing policies \[[@CR21], [@CR24], [@CR32], [@CR34], [@CR41], [@CR46]--[@CR48], [@CR50]--[@CR52]\] pointed to shortcomings in the range of services that should be provided together with HIV testing. These include informed Consent, Confidentiality, Counseling, Correct test results, and Connection to care and treatment, known as the "5 Cs" principles \[[@CR3]\].

In China \[[@CR41]\], Vietnam \[[@CR50]\], India \[[@CR48]\], Uganda \[[@CR51]\], Zambia \[[@CR49]\], Ethiopia \[[@CR47]\] and Russia \[[@CR46]\], lack of confidentiality was reported as a major barrier to HIV testing. Unwillingness to be included in official registers of HIV+ people decreased access to testing in China \[[@CR41]\] and Russia \[[@CR24]\]. In Russia, FSWs without a residence permit or passport are not entitled to accessing healthcare. Free-of-charge HIV testing is available only upon giving up anonymity, and if a woman utilizes state-sponsored HIV testing at a local clinic, the results are officially recorded into her personal medical records \[[@CR24]\]. In India and Ethiopia, to access HIV and AIDS treatment, women are required to show an identity card \[[@CR47], [@CR48]\]. In Uganda, all women diagnosed HIV positive were given two papers indicating test result and further referrals while all diagnosed HIV negative were given one paper with test result only \[[@CR51]\].

FSWs were forced to test against their will or were tested surreptitiously without consent in Kampala (Uganda), Hillbrow and Limpopo (South Africa) \[[@CR52]\] and during police detainment in Uzbekistan \[[@CR32]\] and Macedonia \[[@CR53]\]. In Vietnam, among the FSWs who tested for HIV, only 54% did it voluntarily \[[@CR33]\]. FSWs who had spent time in rehabilitation or detention centers \[[@CR24], [@CR30], [@CR50]\] or had ever been pregnant \[[@CR24], [@CR50]\] were more likely to have undergone HIV testing. In Victoria, Australia, screening of sex workers is mandatory despite its lack of cost-effectiveness \[[@CR21]\].

### Healthcare Funding {#Sec18}

Eleven articles reported how limited healthcare funding decreased HIV testing \[[@CR19], [@CR20], [@CR24], [@CR26], [@CR32], [@CR36], [@CR41], [@CR48], [@CR50]--[@CR52]\]. High medical care costs in China \[[@CR41]\], Iran \[[@CR36]\], several African countries (Kenya, Zimbabwe, Uganda and South Africa) \[[@CR52]\] and informal payments in Russia \[[@CR24]\], Uganda \[[@CR51]\] and India \[[@CR48]\] reduced access to healthcare, including testing. Five articles suggested that free treatment might increase testing \[[@CR19], [@CR20], [@CR26], [@CR47], [@CR50]\].

### Criminalization {#Sec19}

Eight studies reported how current criminalized approaches to sex work and drug use inhibited FSWs from accessing healthcare \[[@CR24], [@CR25], [@CR27], [@CR32], [@CR34], [@CR51], [@CR52], [@CR54]\]. Sex work criminalization in Kenya, Zimbabwe, Uganda and South Africa, Canada, Uzbekistan and Russia \[[@CR24], [@CR25], [@CR27], [@CR32], [@CR51], [@CR52], [@CR54]\] and fear of registration as a drug-user in Russia \[[@CR24], [@CR34]\] are seen to have hampered access to healthcare, including testing.

Testing Modalities {#Sec20}
------------------

A total of twenty studies examined different ways to encourage HIV testing among FSWs including self-testing \[[@CR39], [@CR54]\], home-based \[[@CR25], [@CR29], [@CR42]\], rapid testing \[[@CR35], [@CR43]\], work-based \[[@CR29]\], oral fluid tests \[[@CR42]\], "friendly cabinets" (newly established anonymous testing centers) at public STI clinics \[[@CR32], [@CR51]\], mobile services \[[@CR43]\], outreach with referrals \[[@CR24], [@CR34], [@CR39]\], community mobilization \[[@CR29], [@CR52]\], community empowerment \[[@CR49]\] and involvement of peers, managers and healthcare workers \[[@CR19], [@CR20], [@CR39], [@CR45], [@CR47], [@CR49]--[@CR52]\]. In one study examining hypothetical circumstances around self-testing, participants reported to anticipate significant benefits (entire privacy, avoiding travel and time costs, ability to test before sex early diagnosis), although these same features raised concerns when associated with lack of supportive counseling and linkage to care \[[@CR54]\].

These studies suggest that HIV testing might increase if FSWs can easily access testing sites and receive support from peers, friends and healthcare workers along with educational activities \[[@CR19], [@CR20], [@CR45], [@CR50]--[@CR52]\].

Discussion {#Sec21}
==========

This systematic review of barriers and facilitators to HIV testing amongst FSWs found that the two barriers to HIV testing most commonly reported are (1) costs, including transportation, formal/informal payments, and time, and (2) stigma, including fear of involuntary disclosure of HIV status/history of sex work, negative attitudes of healthcare workers, and discriminatory policies. Social support facilitated HIV testing, with consistently higher uptake amongst married FSWs, and those encouraged to test by peers, healthcare workers or employers.

The majority of the studies reviewed were conducted in low and middle-income countries with only three studies identified in high-income settings. Only one study evaluated the cost-effectiveness of HIV testing amongst FSWs. Most studies addressed micro, or micro and meso levels of the SEM with predominance of micro-level factors. Thirteen studies analyzed concurrently the macro, meso and micro levels. Our findings support previous calls to develop HIV testing strategies that fully account for structural factors \[[@CR55], [@CR56]\] and highlight the need for a more nuanced investigation of how micro-, meso- and macro-level factors intersect to influence HIV testing uptake.

Few studies assessed frequencies of collecting test results or compared them with testing frequencies. The outcome most frequently assessed was "ever in life" testing although this outcome measure fails to capture the frequency of HIV testing. Furthermore, the highest percentage of recently tested FSWs was reported by a Canadian study and constituted 76.1%, an outcome too low to meet either WHO recommendations \[[@CR3], [@CR57]\] or the "90-90-90" target \[[@CR1]\], which highlights necessity to increase efforts to promote HIV testing amongst FSWs. Taken together, our results suggest addressing simultaneously several outcome measures when assessing HIV testing programs among female sex workers, including accessibility of testing, willingness to be tested, regularity and collecting test results.

In line with previous studies of HIV testing behavior of different populations \[[@CR14], [@CR58], [@CR59]\], we found that scarcity of financial resources, low perceived risk and poor HIV knowledge were barriers to HIV testing for FSWs.

Similar to the results reported for female migrants \[[@CR58]\], we observed an association between having children and HIV testing uptake. This might be manifestation of women's and particularly pregnant women's greater exposure to HIV testing, as an offer of HIV testing became generally the norm in reproductive and antenatal care settings \[[@CR3], [@CR60]\]. On the other hand, several papers reviewed suggested that women in permanent relationships and with children might have higher motivation to stay healthy and thus, might seek out testing themselves. For example, in Vietnam, FSWs in permanent relationships were more likely to be tested in the year 2000 before HIV testing became widely implemented as a part of national antenatal health care program across the country \[[@CR61]\]. Overall, social support from family, peers, sex work managers and healthcare workers are instrumental for promoting HIV testing uptake among FSWs, yet the same sources might contribute to further stigma and discrimination.

We did not find any consistent associations between age of participants \[[@CR58]\] or their educational level \[[@CR58], [@CR59]\] and HIV testing, but working in the sex industry for a longer period and starting sex work at older ages were associated with higher HIV testing uptake. These findings suggest that the willingness to test for HIV might increase with time and relate closely with HIV risk awareness.

The inconsistency of results on how condom use and number of clients influenced testing might be explained by FSWs' engagement in different types of concurrent sexual partnerships. While using condoms with commercial clients might be perceived as prevailing acceptable behavior \[[@CR62]\], the decision to use a condom in cohabiting relationships or with a husband might be influenced by interpersonal factors related to partnership intimacy (e.g., trust, emotional closeness, power or reproductive desires) \[[@CR63]\]. Moreover, there is a need to account not only for the type of partnerships, but also for their duration. Consistency of condom use might decrease with longer duration of relationships with non-paying partners \[[@CR63]\], but may increase with commercial permanent partners \[[@CR64]\]. The relationship intimacy may be at play in the HIV testing decision-making process among FSWs and for consistent condom use. Testing behavior might be influenced by increased trust, emotional closeness and familiarity. A more nuanced understanding of how HIV testing behavior is influenced by risky sexual behaviors in different types of partnerships and how it changes over time is needed. In turn, relationship power might be an important modifiable factor, which might be considered when developing HIV testing interventions for FSWs.

The inconsistencies between results in relation to sexual/drug use behavior and HIV testing might be due to differences in targets of HIV testing approaches across countries. For example, in Canada efforts were concentrated on reaching street-based sex workers and those injecting drugs, leaving out those working indoors, in more high-income venues. Nevertheless, at that time sex work was fully decriminalized in Canada \[[@CR65]\]. In contrast, in Uzbekistan and Russia HIV testing might be less accessible for sex workers and drug users because of punitive laws. In these countries, HIV testing is provided solely through government-affiliated settings, including so-called "friendly cabinets" and thus, sex workers and drug users might avoid state clinics or at least avoid disclosing who they are, as they might be stigmatized by healthcare providers or even arrested. Our results demonstrate how laws might diminish promising health-promoting interventions in some countries while in others, supporting policies and concentrated efforts might lead to the successful enrolment of most vulnerable populations.

Furthermore, factors, such as violations of human rights when forcing FSWs to test, lack of confidentiality and anonymity, discriminatory attitudes of healthcare workers, fear of testing HIV+ and being identified as a sex worker and/or a drug user, are manifestations of prevailing stigma. Unfortunately, there are still cases where the violation of basic human rights is "justified" and sex workers are perceived as victims and objects of pity, who should be helped when applying mandatory or forced testing. Our findings highlight the importance to tackle overlapping stigma and discrimination across all three levels of SEM in order to promote HIV testing among sex workers \[[@CR66]\]. This is in line with the WHO's call to enforce the 5 Cs principles and to institutionalize policies preventing discrimination and promoting tolerance towards sex workers and people living with HIV \[[@CR61], [@CR67]\]. As reported before, introduction of discriminative laws and policies criminalizing sex work and/or HIV transmission may fuel stigma \[[@CR65], [@CR68]--[@CR70]\].

This review has several limitations. It is restricted to studies published in English, but only three pre-selected studies were excluded for this reason, so the impact upon the findings is likely to be minimal. We included studies published during the last 17 years to account for recent HIV testing approaches. It is unlikely that the content of previously published articles would have substantially altered our findings, as rapid HIV testing started in the early 2000s. We excluded eight citations with neither abstract, nor title available. We acknowledge that our findings are based on the topics presented by the selected studies, and thus, are restricted by the reported information. Despite the limitations mentioned above, this study provides a broad overview of the different aspects of HIV testing across the global SEM, provides important insights on how HIV testing uptake could be promoted among FSWs, and suggests avenues for further research.

Conclusion {#Sec22}
==========

The consistent finding that social support facilitated HIV testing calls for the inclusion of meso- level factors into current HIV testing strategies directed at FSW. Studies on the role of macro-level factors and their intersections with the meso and micro levels are needed to inform interventions that facilitate HIV testing uptake amongst FSWs.

Annex 1: Search Strategy {#Sec23}
========================

HIV (human Immunodeficiency virus)\
(AND combined with)HIV testing/test/tested\
(AND combined with)Sex work\
(AND combined with)OR acquired immunodeficiency syndrome OR AIDSOR voluntary counselling and testing OR VCTOR people who sell sexOR HIV\
OR human immunodeficiency virusOR provider initiated testing and counselling OR PITCOR sex industry/sex businessOR provider initiated counselling and testing OR PICTOR prostitutionOR diagnostic/diagnosedOR FSW OR female sex workersOR screening/screenedOR CSW OR commercial sex workersOR routine testing, Opt-In, Opt-OutOR sex servicesOR positive resultOR escort servicesOR testing and counselling OR HTCOR paid sexOR transactional sex

The final search strategy was defined as:Search terms for HIV;Search term for Sex workers;Search term for HIV testing;1 AND 2 AND 3.

Date of search: 03/November/2017;

Searched fields: abstract, key words, subject headings, title;

Databases searched:

Results: Ovid MEDLINE(R)-1,877studiesEmbase-2516 studiesSCOPUS-2591 studies

HIV.ab,kw,sh,ti.AIDS.ab,kw,sh,ti.Human Immunodeficiency virus.ab,kw,sh,ti.Acquired Immunodeficiency syndrome.ab,kw,sh,ti.1 or 2 or 3 or 4"test\* ".ab,kw,sh,ti."counsel\* ".ab,kw,sh,ti.HTC.ab,kw,sh,ti.VCT.ab,kw,sh,ti.(Voluntary counsel\* and test\*).ab,kw,sh,ti.(Provider Initiated test\* and counsel\*).ab,kw,sh,ti.PITC.ab,kw,sh,ti.PICT.ab,kw,sh,ti.(Provider Initiated counsel\* and test\*).ab,kw,sh,ti."diagnos\* ".ab,kw,sh,ti."screen\* ".ab,kw,sh,ti."Routine test\* ".ab,kw,sh,ti.Opt-In.ab,kw,sh,ti.OPt-Out.ab,kw,sh,ti.Positive results.ab,kw,sh,ti.6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20"Sex\* work\* ".ab,kw,sh,ti."people who sell sex\* ".ab,kw,sh,ti."sex\* industry ".ab,kw,sh,ti."sex\* business ".ab,kw,sh,ti."sex\* service\* ".ab,kw,sh,ti."prostitut\* ".ab,kw,sh,ti."female sex\* work\* ".ab,kw,sh,ti."commercial sex\* work\* ".ab,kw,sh,ti."Escort\* service\* ".ab,kw,sh,ti."paid sex\* ".ab,kw,sh,ti."transactional sex\* ".ab,kw,sh,ti."FSW\* ".ab,kw,sh,ti."CSW\* ".ab,kw,sh,ti.22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 345 and 21 and 35("2000" or "2001" or "2002" or "2003" or "2004" or "2005" or "2006" or "2007" or "2008" or "2009" or "2010" or "2011" or "2012" or "2013" or "2014" or "2015" or "2016" or "2017").yr.36 and 37

Annex 2: Data Extraction Form {#Sec24}
=============================

TitleDate publishedDate of researchAuthorsStudy designResearch objectives/research questionsCountryStudy populationMain methods of researchMain resultsMain conclusionsComments\*(if needed)

Annex 3: Quality Assessment {#Sec25}
===========================

The quality of the qualitative papers (Table [1](#Tab1){ref-type="table"}) was assessed using the guide for critically appraising qualitative research \[[@CR15]\].The checklist consisted of 18 items assessing findings, design, sample, data collection, analysis, reporting, reflexivity and neutrality, ethics and auditability. As in previous research \[[@CR66]\] we used a midpoint score of 9 as a cut off between low- and high-quality studies.

We assessed the quality of the quantitative and mixed-methods papers using the modified *Downs and Black* checklist \[[@CR16]\]. The 26 questions of the checklist represented items of reporting, external and internal validity, and power. As the majority of studies did not report power calculations of the sample size and none was single or double blinded, we excluded the power (\#27) and the blinding (\#13, 14) questions. Thus, the modified checklist consisted of 24 questions with a maximum score of 25 points). A midpoint score of 12.5 was considered to distinguish the high-quality studies (Table [2](#Tab2){ref-type="table"}).Table 2Quality assessment of the 36 studiesStudy referenceStudy designSummary score for quality assessmentQualitative methods (Spencer et al. \[[@CR15]\]) Ameyan et al. \[[@CR47]\]QL61% (11/18) Beattie et al. \[[@CR48]\]QL72% (13/18) Burke et al. \[[@CR54]\]QL61% (11/18) Chanda et al. \[[@CR49]\]QL67% (12/18) Dugas et al. \[[@CR29]\]QL50% (9/18) King et al. \[[@CR46]\]QL50% (9/18) Ngo et al. \[[@CR50]\]QL72% (13/18) Scorgie et al. \[[@CR52]\]QL67% (12/18) Wang et al. \[[@CR41]\]QL67% (12/18) Wanyenze et al. \[[@CR51]\]QL72% (13/18)Quantitative methods (modified Downs and Black \[[@CR16]\]) Batona et al. \[[@CR28]\]QN56% (14/25) Bengtson et al. \[[@CR27]\]QN52% (13/25) Chiao et al. \[[@CR45]\]QN72% (18/25) Dandona et al. \[[@CR18]\]QN40% (10/25) Deering et al. \[[@CR25]\]QN60% (15/25) Grayman et al. \[[@CR30]\]QN48% (12/25) Hong et al. \[[@CR31]\]QN52% (13/25) Johnston et al. \[[@CR40]\]QN64% (16/25) King et al. \[[@CR46]\]QN52% (13/25) Nhurod et al. \[[@CR43]\]QN56% (14/25) Parriault et al. \[[@CR17]\]QN36% (9/25) Shokoohi et al. \[[@CR35]\]QN56% (14/25) Shokoohi et al. \[[@CR35]\]QN60% (15/25) Todd et al. \[[@CR32]\]QN52% (13/25) Tran et al. \[[@CR33]\]QN52% (13/25) Wang et al. \[[@CR19]\]QN48% (12/25) Wang et al. \[[@CR20]\]QN48% (12/25) Wilson et al. \[[@CR21]\]QN, mathematical modelingn/a Xun et al. \[[@CR42]\]QN56% (14/25) Xu et al. \[[@CR23]\]QN64% (16/25)Mixed methods (modified Downs and Black \[[@CR16]\]) Aho et al. \[[@CR26]\]QN & QL68% (17/25) King et al. \[[@CR34]\]QN & QL48 (12/25)Abstracts Deering et al. \[[@CR37]\]QNn/a Park et al. \[[@CR38]\]QNn/a Sayarifard et al. \[[@CR36]\]QNn/a Simonovikj et al. \[[@CR53]\]Case reportn/a*QL* qualitative, *QN* quantitative

Annex 4: PRISMA 2009 checklist {#Sec26}
==============================

Section/topic\#Checklist itemReported (Yes/No)Title Title1Identify the report as a systematic review, meta-analysis, or both.YesAbstract Structured summary2Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.YesIntroduction Rationale3Describe the rationale for the review in the context of what is already known.Yes Objectives4Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).Not applicableMethods Protocol and registration5Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.Not available Eligibility criteria6Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.Yes Information sources7Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.Yes Search8Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.Yes ("[Annex 1: Search strategy](#Sec23){ref-type="sec"}") Study selection9State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).Yes (Fig. [1](#Fig1){ref-type="fig"}) Data collection process10Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.Yes ("[Annex 2: Data extraction form](#Sec24){ref-type="sec"}") Data items11List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.Yes Risk of bias in individual studies12Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.Not available Summary measures13State the principal summary measures (e.g., risk ratio, difference in means).Yes Synthesis of results14Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I^2^) for each meta-analysis.Not applicable Risk of bias across studies15Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).Yes Additional analyses16Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.Not availableResults Study selection17Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.Yes (Fig. [1](#Fig1){ref-type="fig"}) Study characteristics18For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.Yes (Table [1](#Tab1){ref-type="table"}) Risk of bias within studies19Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).Not available Results of individual studies20For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.Not applicable Synthesis of results21Present results of each meta-analysis done, including confidence intervals and measures of consistency.Not applicable Risk of bias across studies22Present results of any assessment of risk of bias across studies (see Item 15).Yes Additional analysis23Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression \[see Item 16\]).Not availableDiscussion Summary of evidence24Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).Yes (Table [1](#Tab1){ref-type="table"}) Limitations25Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).Yes Conclusions26Provide a general interpretation of the results in the context of other evidence, and implications for future research.YesFunding Funding27Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.Not available

Moher et al. \[[@CR71]\]. For more information, visit: [www.prisma-statement.org](http://www.prisma-statement.org).
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